<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Li RN</submitter><pubmed_abstract>Type I epithelial ovarian cancer (EOC) is primarily resistant to platinum-based chemotherapies and needs novel therapeutics. Given the aberrant Wnt activation in type I EOC and the involvement of Dapper1 Antagonist of Catenin-1 (DACT1) in Wnt signalling, the role of DACT1 in tumourigenesis of type I EOC was evaluated. Firstly, all tested EOC cell lines and primary EOC tissues, especially type I EOC, were observed to have significantly lower DACT1 expression than normal controls. Next, 3AO cells, which arise from a patient with primary mucinous EOC and express low endogenous levels of DACT1, were transfected with a lentivirus carrying full-length DACT1 (3AO-DACT1), grew slower and formed smaller tumours in nude mice compared to 3AO-NC. Furthermore, 3AO-DACT1 had lower levels of key mediator</pubmed_abstract><journal>Scientific reports</journal><pagination>9285</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5570946</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy.</pubmed_title><pmcid>PMC5570946</pmcid><pubmed_authors>Li RN</pubmed_authors><pubmed_authors>Linghu H</pubmed_authors><pubmed_authors>Li XM</pubmed_authors><pubmed_authors>Hou LS</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Mu XL</pubmed_authors></additional><is_claimable>false</is_claimable><name>DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy.</name><description>Type I epithelial ovarian cancer (EOC) is primarily resistant to platinum-based chemotherapies and needs novel therapeutics. Given the aberrant Wnt activation in type I EOC and the involvement of Dapper1 Antagonist of Catenin-1 (DACT1) in Wnt signalling, the role of DACT1 in tumourigenesis of type I EOC was evaluated. Firstly, all tested EOC cell lines and primary EOC tissues, especially type I EOC, were observed to have significantly lower DACT1 expression than normal controls. Next, 3AO cells, which arise from a patient with primary mucinous EOC and express low endogenous levels of DACT1, were transfected with a lentivirus carrying full-length DACT1 (3AO-DACT1), grew slower and formed smaller tumours in nude mice compared to 3AO-NC. Furthermore, 3AO-DACT1 had lower levels of key mediator</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2026-05-06T00:17:51.559Z</modification><creation>2019-03-27T02:54:30Z</creation></dates><accession>S-EPMC5570946</accession><cross_references><pubmed>28839145</pubmed><doi>10.1038/s41598-017-08249-7</doi></cross_references></HashMap>